| |
Sample size (n) |
Metabolic syndrome* |
Metabolic syndrome** |
Abdominal obesity# |
Hypertriglyceridemia# |
Low HDL cholesterol# |
High blood pressure# |
Hyperglycemia# |
| Total participants |
899 |
3.60% |
1.50% |
3.70% |
31% |
17% |
4% |
9.80% |
| Age (years) |
| 12-Oct |
218 |
2.70% |
0.40% |
4.70% |
33% |
17% |
2.80% |
18.80% |
| 13-15 |
219 |
6.80% |
2.70% |
10.00% |
27.40% |
21.90% |
7.80% |
13.60% |
| 16-18 |
462 |
2.50% |
1.50% |
6% |
32.10% |
17.20% |
4.50% |
3.40% |
| P for linear trend |
|
0.01 |
0.08 |
0.04 |
0.9 |
0.1 |
0.03 |
0.01 |
| Sex |
|
| Male |
311 |
3.80% |
1.90% |
3% |
26% |
18% |
4% |
12% |
| Female |
588 |
3.50% |
1.30% |
4% |
35% |
16% |
3.80% |
5% |
| P |
|
0.69 |
0.12 |
0.2 |
0.03 |
1 |
1.01 |
0.02 |
*Metabolic Syndrome (ATPIII criteria)
**Metabolic Syndrome (IDF criteria)
#Factor analysis (ATPIII criteria) |
